ATE399777T1 - Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors - Google Patents
Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptorsInfo
- Publication number
- ATE399777T1 ATE399777T1 AT04749150T AT04749150T ATE399777T1 AT E399777 T1 ATE399777 T1 AT E399777T1 AT 04749150 T AT04749150 T AT 04749150T AT 04749150 T AT04749150 T AT 04749150T AT E399777 T1 ATE399777 T1 AT E399777T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrrole
- modulators
- liver
- receptor
- dione derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0316232.8A GB0316232D0 (en) | 2003-07-11 | 2003-07-11 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE399777T1 true ATE399777T1 (de) | 2008-07-15 |
Family
ID=27741983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04749150T ATE399777T1 (de) | 2003-07-11 | 2004-07-08 | Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors |
Country Status (26)
Country | Link |
---|---|
US (1) | US7432288B2 (de) |
EP (1) | EP1646626B1 (de) |
JP (1) | JP2007521312A (de) |
KR (1) | KR20060035748A (de) |
CN (1) | CN1823061A (de) |
AR (1) | AR045721A1 (de) |
AT (1) | ATE399777T1 (de) |
AU (1) | AU2004255999B2 (de) |
BR (1) | BRPI0412472A (de) |
CA (1) | CA2532056A1 (de) |
DE (1) | DE602004014773D1 (de) |
ES (1) | ES2308204T3 (de) |
GB (1) | GB0316232D0 (de) |
HK (1) | HK1088320A1 (de) |
IL (1) | IL172760A0 (de) |
IS (1) | IS8293A (de) |
MX (1) | MXPA06000414A (de) |
MY (1) | MY135821A (de) |
NO (1) | NO20060081L (de) |
RU (1) | RU2006102130A (de) |
SA (1) | SA04250204B1 (de) |
TW (1) | TW200503691A (de) |
UA (1) | UA82109C2 (de) |
UY (1) | UY28408A1 (de) |
WO (1) | WO2005005417A1 (de) |
ZA (1) | ZA200600222B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1634877B1 (de) * | 2004-08-17 | 2011-06-22 | Simpson Biotech Co., Ltd. | Mischung und Verbindungen von Mycelien von Antrodia Camphorata und deren Verwendung |
US7505238B2 (en) * | 2005-01-07 | 2009-03-17 | Agnes Neves Woo | ESD configuration for low parasitic capacitance I/O |
CA2592771A1 (en) | 2005-01-10 | 2006-07-13 | Astrazeneca Ab | Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
SE0500055D0 (sv) | 2005-01-10 | 2005-01-10 | Astrazeneca Ab | Therapeutic agents 3 |
ES2433135T3 (es) * | 2006-04-28 | 2013-12-09 | Laboratorios Del Dr. Esteve, S.A. | Compuestos biciclicos de tetrahidropirrol |
CA2660963A1 (en) | 2006-08-21 | 2008-02-28 | Genentech, Inc. | Aza-benzothiophenyl compounds and methods of use |
CN101456863B (zh) * | 2007-12-14 | 2012-04-25 | 华北制药集团新药研究开发有限责任公司 | Lxr激动剂及其制备方法和用途 |
PE20110424A1 (es) | 2008-07-01 | 2011-07-22 | Genentech Inc | Isoindolonas que inhiben la cinasa mek |
MX2010014559A (es) | 2008-07-01 | 2011-03-04 | Genentech Inc | Heterociclos bicíclicos sustituidos y metodos de uso. |
US20130274212A1 (en) | 2010-09-07 | 2013-10-17 | Snu R&Db Foundation | Sesterterpene Compounds and Use Thereof |
WO2012074780A1 (en) | 2010-12-03 | 2012-06-07 | Allergan, Inc. | Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
EP2646114B1 (de) | 2010-12-03 | 2014-10-22 | Allergan, Inc. | Neuartige oximderivate als sphingosin-1-phosphat (s1p)-rezeptormodulatoren |
CA2939120A1 (en) | 2014-01-10 | 2015-07-16 | Rgenix, Inc. | Lxr agonists and uses thereof |
CN109069461A (zh) | 2016-01-11 | 2018-12-21 | 洛克菲勒大学 | 与髓源性抑制细胞相关的病症的治疗方法 |
CA3078981A1 (en) | 2017-11-21 | 2019-05-31 | Rgenix, Inc. | Polymorphs and uses thereof |
ES2982346T3 (es) | 2019-12-13 | 2024-10-15 | Inspirna Inc | Sales metálicas y usos de las mismas |
US11753374B2 (en) * | 2020-11-18 | 2023-09-12 | Southern Reserach Institute | Compounds for the treatment of acute and chronic kidney disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID27510A (id) | 1998-07-30 | 2001-04-12 | Japan Tobacco Inc | Senyawa malimida tersubstitusi dan penggunaan farmasinya |
ES2234300T3 (es) | 1998-10-08 | 2005-06-16 | Smithkline Beecham Plc | 3-(3-cloro-4-hidroxifenilamino)-4-(2-nitrofenil)-1h-pirrol-2,5-diona como inhibidor de glucogeno cinasa-3 (gsk-3)sintetasa. |
AU6074700A (en) | 1999-07-08 | 2001-01-30 | Tularik Inc. | Compositions and methods for raising hdl cholesterol levels |
EP1224932A4 (de) | 1999-08-20 | 2002-10-16 | Sagami Chem Res | Wirkstoffe zur hemmung des zelltods |
GB0008264D0 (en) | 2000-04-04 | 2000-05-24 | Smithkline Beecham Plc | Novel method and compounds |
-
2003
- 2003-07-11 GB GBGB0316232.8A patent/GB0316232D0/en not_active Ceased
-
2004
- 2004-06-29 TW TW093119064A patent/TW200503691A/zh unknown
- 2004-07-05 SA SA4250204A patent/SA04250204B1/ar unknown
- 2004-07-08 KR KR1020067000712A patent/KR20060035748A/ko not_active Application Discontinuation
- 2004-07-08 CN CNA2004800198411A patent/CN1823061A/zh active Pending
- 2004-07-08 WO PCT/SE2004/001114 patent/WO2005005417A1/en active IP Right Grant
- 2004-07-08 AT AT04749150T patent/ATE399777T1/de not_active IP Right Cessation
- 2004-07-08 CA CA002532056A patent/CA2532056A1/en not_active Abandoned
- 2004-07-08 EP EP04749150A patent/EP1646626B1/de not_active Expired - Lifetime
- 2004-07-08 AR ARP040102419A patent/AR045721A1/es not_active Application Discontinuation
- 2004-07-08 JP JP2006520138A patent/JP2007521312A/ja not_active Withdrawn
- 2004-07-08 MX MXPA06000414A patent/MXPA06000414A/es not_active Application Discontinuation
- 2004-07-08 AU AU2004255999A patent/AU2004255999B2/en not_active Ceased
- 2004-07-08 BR BRPI0412472-3A patent/BRPI0412472A/pt not_active IP Right Cessation
- 2004-07-08 US US10/564,235 patent/US7432288B2/en not_active Expired - Fee Related
- 2004-07-08 ES ES04749150T patent/ES2308204T3/es not_active Expired - Lifetime
- 2004-07-08 DE DE602004014773T patent/DE602004014773D1/de not_active Expired - Fee Related
- 2004-07-08 RU RU2006102130/04A patent/RU2006102130A/ru not_active Application Discontinuation
- 2004-07-09 MY MYPI20042745A patent/MY135821A/en unknown
- 2004-07-09 UY UY28408A patent/UY28408A1/es unknown
- 2004-08-07 UA UAA200600272A patent/UA82109C2/uk unknown
-
2005
- 2005-12-22 IL IL172760A patent/IL172760A0/en unknown
-
2006
- 2006-01-05 NO NO20060081A patent/NO20060081L/no not_active Application Discontinuation
- 2006-01-10 ZA ZA200600222A patent/ZA200600222B/en unknown
- 2006-02-09 IS IS8293A patent/IS8293A/is unknown
- 2006-08-08 HK HK06108803.4A patent/HK1088320A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20060035748A (ko) | 2006-04-26 |
UA82109C2 (uk) | 2008-03-11 |
IL172760A0 (en) | 2006-04-10 |
AR045721A1 (es) | 2005-11-09 |
CN1823061A (zh) | 2006-08-23 |
CA2532056A1 (en) | 2005-01-20 |
BRPI0412472A (pt) | 2006-09-19 |
DE602004014773D1 (de) | 2008-08-14 |
EP1646626A1 (de) | 2006-04-19 |
MY135821A (en) | 2008-07-31 |
HK1088320A1 (en) | 2006-11-03 |
UY28408A1 (es) | 2005-02-28 |
AU2004255999B2 (en) | 2007-08-02 |
NO20060081L (no) | 2006-02-08 |
EP1646626B1 (de) | 2008-07-02 |
TW200503691A (en) | 2005-02-01 |
ES2308204T3 (es) | 2008-12-01 |
GB0316232D0 (en) | 2003-08-13 |
WO2005005417A1 (en) | 2005-01-20 |
SA04250204B1 (ar) | 2008-03-23 |
RU2006102130A (ru) | 2007-08-20 |
US7432288B2 (en) | 2008-10-07 |
MXPA06000414A (es) | 2006-03-17 |
US20060235015A1 (en) | 2006-10-19 |
AU2004255999A1 (en) | 2005-01-20 |
IS8293A (is) | 2006-02-09 |
ZA200600222B (en) | 2007-04-25 |
JP2007521312A (ja) | 2007-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1088320A1 (en) | Pyrrole-2, 5-dione derivatives as liver x receptor modulators | |
ATE440085T1 (de) | 3-substituierte 1,5-diphenylpyrazolderivate, die sich als cb1-modulatoren eignen | |
HK1088318A1 (en) | Pyrrole-2, 5-dithione derivatives as liver x receptor modulators | |
ATE439357T1 (de) | Indolylderivate als liver-x-rezeptormodulatoren | |
ATE451364T1 (de) | Als modulatoren des dopamin-d3-rezeptors geeignete azabicycloä3.1.0ühexanderivate | |
ATE420881T1 (de) | Kondensierte heterocyclische verbindungen als modulatoren des serotoninrezeptors | |
MA28391B1 (fr) | Dérivés de 3-cycloalkylaminopyrrolidine utiles comme modulateurs de récepteurs de chimiokines | |
IL180630A0 (en) | Pyrrole derivatives as pharmaceutical agents | |
DE60317630D1 (de) | Indol, azaindol und verwandte heterocyclische pyrrolidin-derivate | |
DE602005027307D1 (de) | Arylanilinderivate als agonisten des beta2-adrenergen rezeptors | |
DE602006013878D1 (de) | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel | |
DE602005009748D1 (de) | 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors | |
NL2000241A1 (nl) | Carboxamidederivaten als muscarine-receptorantagonisten. | |
ATE387202T1 (de) | Pyrrolidinderivate als histaminrezeptor-liganden | |
DE602004021394D1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
ZA200804349B (en) | 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as H3 modulators | |
ATE377008T1 (de) | Imidazolderivate als glutamatrezeptorantagonisten | |
AU2003205964A1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
SI1828154T1 (sl) | Derivati fenil-piperazin metanona | |
AU2003214520A1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
BRPI0509256A (pt) | derivados de pirrolidina-3,4-dicarboxamida | |
AU2003223010A1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
AU2003278403A1 (en) | 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist | |
ATE398620T1 (de) | Spirokondensierte indolinderivate als pestizide | |
DE602004009583D1 (de) | Piperidin- oder 8-azabicycloä3.2.1üoct-3-ylderivate, die sich als modulatoren der chemokinrezeptoraktivität eignen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |